Endoluminal robotics may represent one of the most significant technological shifts in gastroenterology since the advent of modern endoscopy. According to medtech strategist Steve Bell, robotic platforms designed for the gastrointestinal tract could dramatically expand the range of procedures that can be performed endoscopically—potentially transforming GI from a primarily diagnostic specialty into a truly interventional field.
Today, many advanced endoscopic procedures—including endoscopic mucosal resection (EMR), endoscopic submucosal dissection (ESD), and endoscopic sleeve gastroplasty (ESG)—remain limited by operator skill, long procedure times, and inconsistent outcomes. These factors restrict adoption, particularly outside highly specialized centers in Asia where training and expertise are concentrated.
Robotic endoluminal platforms could address many of these limitations by introducing bi-manual dexterity, improved visualization, and stable operating platforms inside the GI tract. In doing so, they may reduce the technical complexity of advanced procedures and make them accessible to a much broader group of physicians.